Montelukast Tablet
Product Images NDC 68071-4034

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 68071-4034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4034 09

Montelukast Sodium 10 mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets with a product number R1529090. It includes multiple national drug code (NDC) numbers and packaging details. The label also contains storage instructions and a warning to keep out of reach of children.*

FDA Label Image

Montelukast-fig-1 (Montelukast Fig 1)

A line graph comparing mean percent change from baseline over weeks in treatment for Montelukast Sodium versus placebo. The x-axis represents weeks in treatment from 0 to 15, and the y-axis shows mean percent change from baseline. Montelukast Sodium shows a higher percent change, peaking around week 12 before a washout period, while placebo shows a gradual modest increase over time.*

FDA Label Image

Montelukast-structural (Montelukast Structural)

Chemical structure of Montelukast sodium, showing its detailed molecular arrangement with aromatic rings, sulfur atoms, and the sodium carboxylate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.